These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 19890226

  • 1. A mathematical model to improve on phenotyping for molecular genetic research in malignant hyperthermia.
    Ginz HF, Rüffert H, Levano S, Li Wan Po A, Benthien J, Urwyler A, Girard T.
    Pharmacogenet Genomics; 2009 Dec; 19(12):972-8. PubMed ID: 19890226
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Current aspects of the diagnosis of malignant hyperthermia].
    Rüffert H, Olthoff D, Deutrich C, Froster UG.
    Anaesthesist; 2002 Nov; 51(11):904-13. PubMed ID: 12434264
    [Abstract] [Full Text] [Related]

  • 5. Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families.
    Kaufmann A, Kraft B, Michalek-Sauberer A, Weindlmayr M, Kress HG, Steinboeck F, Weigl LG.
    Anesth Analg; 2012 May; 114(5):1017-25. PubMed ID: 22415532
    [Abstract] [Full Text] [Related]

  • 6. Mild clinical and histopathological features in patients who carry the frequent and causative malignant hyperthermia RyR1 mutation p.Thr2206Met.
    Rueffert H, Wehner M, Ogunlade V, Meinecke C, Schober R.
    Clin Neuropathol; 2009 May; 28(6):409-16. PubMed ID: 19919814
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
    Klein W, Spiess-Kiefer C, Küther G, Pongratz D, Lehmann-Horn F.
    Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family.
    Steinfath M, Seranski P, Singh S, Fiege M, Wappler F, Schulte Am Esch J, Scholz J.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):372-5. PubMed ID: 12237752
    [Abstract] [Full Text] [Related]

  • 10. Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia.
    Anderson AA, Brown RL, Polster B, Pollock N, Stowell KM.
    Anesthesiology; 2008 Feb; 108(2):208-15. PubMed ID: 18212565
    [Abstract] [Full Text] [Related]

  • 11. Genotype-phenotype comparison of the Swiss malignant hyperthermia population.
    Girard T, Urwyler A, Censier K, Mueller CR, Zorzato F, Treves S.
    Hum Mutat; 2001 Oct; 18(4):357-8. PubMed ID: 11668625
    [Abstract] [Full Text] [Related]

  • 12. Novel ryanodine receptor mutation that may cause malignant hyperthermia.
    Kaufmann A, Kraft B, Michalek-Sauberer A, Weigl LG.
    Anesthesiology; 2008 Sep; 109(3):457-64. PubMed ID: 18719443
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A fulminant malignant hyperthermia episode in a patient with ryanodine receptor gene mutation p.Tyr522Ser.
    Girard T, Suhner M, Levano S, Singer M, Zollinger A, Hofer CK.
    Anesth Analg; 2008 Dec; 107(6):1953-5. PubMed ID: 19020143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.